An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT01488162 · COMPLETED
Trial details
- NCT number
- NCT01488162
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-04-04
- Primary completion
- 2016-10-24
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.